Alnylam Pharmaceuticals
ALNY
#586
Rank
S$46.45 B
Marketcap
$360.14
Share price
0.32%
Change (1 day)
46.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company